Westerkirk Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.89M Hold
38,959
0.95% 21
2026
Q1
$9.52M Sell
38,959
-1,100
-3% -$256K 1.03% 21
2025
Q4
$8.29M Buy
40,059
+5,000
+14% +$989K 0.81% 26
2025
Q3
$6.5M Buy
35,059
+7,775
+28% +$1.33M 0.74% 25
2025
Q2
$4.17M Buy
+27,284
New +$4.19M 0.51% 42

Other funds holding JNJ

Westerkirk Capital's JNJ Position: Q2 2026 in Review

Westerkirk Capital held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 38,959 shares worth $9.89M. The position accounts for 0.95% of the portfolio, ranked #21.

Westerkirk Capital first reported a position in JNJ in Q2 2025 and has held it in 5 quarters since. 4,689 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Westerkirk Capital held 38,959 shares of Johnson & Johnson worth $9.89M as of Q2 2026.
  • Westerkirk Capital left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.95% of Westerkirk Capital's portfolio in Q2 2026, its #21 holding.
  • Westerkirk Capital first reported a position in Johnson & Johnson in Q2 2025 and has held it in 5 quarters since.
  • 4,689 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.